Chinese chemical industry news

• 

  24 March 2026

  Sinopec Reports 2025 Results in Hong Kong

  2025 results: revenue RMB2.78T; profit RMB32.476B; EPS RMB0.268; dividend RMB0.20/share. Oil/gas output rose; refining, chemicals and fuel sales grew; tech/digital advances.
• 

  23 March 2026

  Sinopec Chairman Hou Qijun Meets TotalEnergies CEO Patrick Pouyanné

  Meeting covered cooperation in oil and gas exploration and development, LNG trade, engineering services and new energy; a group vice president attended.
• 

  23 March 2026

  Sinopec expands POE capacity with China's first full‑chain domestic IP

  100kt solution‑method POE unit began linkage trials; with a 50kt demo and another 100kt under construction, domestic POE capacity reaches 250kt/yr. Metallocene catalyst + low‑VOC devolatilization enable varied grades for PV/EVs.
• 

  23 March 2026

  Hou Qijun Meets BASF Chairman Kairi to Discuss Chemical Cooperation

  On March 22 at headquarters, leaders held in-depth talks on deepening cooperation in the chemical sector; the group's vice general manager attended.
• 

  23 March 2026

  Sinopec Among China's Top EV Charging Operators

  2025 charging platform exceeded 5 billion kWh (~200% YoY). It is rapidly expanding charging and battery-swap networks with Aodong, NIO and CATL to broaden oil‑gas‑hydrogen‑electric services.
• 

  23 March 2026

  GSK’s risvutatug rezetecan granted orphan drug designation for SCLC in Japan

  Risvutatug rezetecan, a B7-H3–targeted ADC, showed durable responses in extensive‑stage SCLC in phase I ARTEMIS‑001; global phase III in relapsed ES‑SCLC is underway.

• 

  23 March 2026

  Siemens expands industrial AI OS, unveils new tech and Alibaba Cloud partnership

  Introduces 26 edge, automation and control products, cloud-enabled CAE, DC circuit breakers, AI cooling for data centers, upgraded PLCs, servo systems and predictive maintenance apps.
• 

  20 March 2026

  FUCHS posts solid FY 2025 results

  FY2025: sales €3.56bn, EBIT €435m; EPS +2%; dividend +5% to €1.23/€1.22; free cash flow €316m. 2026 outlook: sales ~€3.7bn, EBIT ~€450m
• 

  19 March 2026

  QatarEnergy: Missile strikes cut LNG export capacity 17%, $20bn annual loss

  Missile strikes at Ras Laffan damaged LNG Trains 4 & 6; repairs may take 3–5 years with force majeure on contracts. Pearl GTL offline ≥1 year; condensate, LPG, naphtha and helium production affected.
• 

  19 March 2026

  GSK: Lynavoy (linerixibat) FDA-approved for cholestatic pruritus in PBC

  FDA approved linerixibat for cholestatic pruritus in adults with PBC after GLISTEN phase III showed rapid, sustained itch and sleep improvements. Common AEs: diarrhea, abdominal pain.
• 

  19 March 2026

  BASF opens world's first industrial 3D‑printed catalyst plant in Ludwigshafen

  X3D 3D-printed catalysts offer geometries that cut pressure drop, increase active surface and throughput, lower energy use; proven in customer plants.
• 

  19 March 2026

  Sinopec Wins Six Awards at 51st Geneva International Invention Exhibition

  Two Jury Special Commendation Golds and four Golds; CO2-capture equipment also won a Special Innovation Award. Winners cover CO2 capture, heavy‑oil viscosity reduction, hydrogen and catalyst tech.
• 

  19 March 2026

  Sinopec Completes Polymer Solid-State Battery Microgrid Demonstration

  Polymer solid-state battery microgrid demo at Suzhou uses polymer solid electrolytes with TOPCon flexible and perovskite PV; upgraded storage and intelligent microgrid raised peak daily charging 47%
• 

  18 March 2026

  Evonik unveils SPHINOX® Vively sphingolipid

  Designer sphingolipid delivers retinol-like rejuvenation with improved tolerance; stimulates elastin, hyaluronic acid and ceramides, reduces IL-1α; biotech-derived, biodegradable; debuts at PCHi 2026
• 

  18 March 2026

  Refining and Chemical Engineering Group 2025 results

  2025: operating revenue RMB700.74B, net profit RMB18.07B; new contracts RMB1,012.48B; first-time special dividend; tech licensing RMB10.13B; overseas front-end wins; front-end/EPC >80% backlog; ESG AA
• 

  18 March 2026

  Clariant unveils Plantasens, Aristoflex SUN and Lucas Meyer blue‑biotech active at PCHi 2026

  New emulsifier boosts barrier, hydrates and stabilizes up to 30% oil. Rheology modifier (+0.5%) raised SPF 75% for light textures. Blue‑biotech beats HA; Lysofix soothes skin, fortifies hair.
• 

  17 March 2026

  Aptar appoints Gael Touya CEO effective Sept 1, 2026; Stephan Tanda to retire end-2026

  Gael Touya, a 30-year veteran, led the Pharma unit’s transformation (~82% sales growth) and has global commercial and operational experience. Tanda raised margins, EPS and sustainability.
• 

  17 March 2026

  Brenntag opens Life Sciences Innovation Center in Shanghai

  Expands application expertise for Beauty & Care and Food & Nutrition; offers formulation development, testing, small-batch trials and product concept support for China & Hong Kong clients.
• 

  17 March 2026

  Clariant Enhances Agricultural Solutions at CAC 2026

  Clariant introduces Dispersogen PSL 100 and Tonnegel 50 for improved formulation stability and rheology in agriculture, supporting biological crop protection and operational efficiency.
• 

  16 March 2026

  Neste Advocates Strong Anti-Fraud Measures in Biofuels Supply Chains

  Neste emphasizes rigorous supplier audits, traceability, and collaboration to combat fraud in renewable raw materials, ensuring compliance and authenticity in its supply chains.
• 

  16 March 2026

  Arkema Boosts Kynar® PVDF Capacity in China

  Arkema expands Changshu site by 20% to meet rising demand in Asia-Pacific for Kynar® PVDF, targeting EV batteries, coatings, and more, with a 2028 start-up.
• 

  13 March 2026

  Trinseo 2025 Q4 and Full-Year Financial Results

  Q4 net loss of $251M, full-year loss of $546M. Sales down 19% in Q4, 15% annually. Restructuring costs impacted results. Adjusted EBITDA stable in Q4, down $41M annually.
• 

  12 March 2026

  WuXi Biologics and Earendil Labs Partner to Develop Antibodies and ADCs

  The collaboration aims to speed up development and manufacturing of bispecific/multispecific antibodies and ADCs for autoimmune diseases and cancer, leveraging AI and advanced biologics expertise.
• 

  12 March 2026

  ORLEN Expands LNG Fleet with Two New Carriers

  Two advanced LNG carriers boost energy security, operational flexibility, and global trade capabilities, supporting Poland's energy transition and regional gas supply.
• 

  12 March 2026

  Brenntag 2025 Financial Results Released

  Revenue at EUR 15.2B, Operating EBITDA down 8.6%. Strong cash flow, cost savings on track. Dividend cut by 10%. 2026 EBITDA forecast: EUR 1,150-1,350M amid challenging market conditions.
• 

  11 March 2026

  Sinopec Launches Recycling Technology Co.

  In Nanjing, a new company focuses on waste plastic recycling, supporting green development with investment, resource management, and technology, aiming for global leadership in resource recycling.
• 

  11 March 2026

  Elkem Restructures and Cuts Costs to Boost Competitiveness

  Elkem introduces a new structure, reduces workforce by 300, and cuts costs by NOK 1.9 billion to enhance profitability amid market challenges.
• 

  10 March 2026

  BASF Expands Ultrason® P Portfolio for EU Food-Contact Compliance

  Six new PPSU grades comply with EU regulations, enabling a smooth transition for manufacturers of high-temperature food-contact articles.
• 

  9 March 2026

  Sinopec Leads Hydrogen Standardization in Energy Industry

  A new committee aims to enhance hydrogen industry standards, drive innovation, and regulate the market, marking a key step for China's hydrogen energy sector.
• 

  9 March 2026

  GSK and Alfasigma License Agreement for Linerixibat Rights

  Alfasigma gains global rights to develop and market linerixibat for cholestatic pruritus in PBC. GSK to receive payments and royalties. Regulatory reviews are ongoing.